Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Anand B, Jain"'
Autor:
Chin Meng Khoo, Su-Yen Goh, Ngiap Chuan Tan, Anand B. Jain, Teck Shi Tan, Rinkoo Dalan, Agnes Koong, Arvind Vilas Gadekar, Yong Mong Bee, Eric Yin Hao Khoo
Publikováno v:
Singapore Med J
Introduction Hypoglycaemia constitutes a significant barrier to achieving glycaemic control with insulin in both Type 1 (T1DM) and Type 2 diabetes mellitus (T2DM). The International Operations Hypoglycaemia Assessment Tool (IO HAT) study was designed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46446cc3bdfe940bedcd4c6e002cf639
https://pubmed.ncbi.nlm.nih.gov/32488272
https://pubmed.ncbi.nlm.nih.gov/32488272
Autor:
Su-Yen Goh, Achmad Rudijanto, Anand B. Jain, Faruque Pathan, Nemencio A. Nicodemus, Arvind Vilas Gadekar
Publikováno v:
Journal of the ASEAN Federation of Endocrine Societies
Objective To provide real-world data on hypoglycaemia incidence in patients with type 1 (T1D) or type 2 diabetes (T2D) from the Southeast Asian cohort of the International Operations Hypoglycaemia Assessment Tool (IO HAT) study. Methodology IO HAT wa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c92f7031ab451a8b325c8042fe2aeac7
http://europepmc.org/articles/PMC7784114
http://europepmc.org/articles/PMC7784114
Publikováno v:
Journal of the ASEAN Federation of Endocrine Societies
Objective. To determine the frequency of hypoglycemia in insulin-treated patients with type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM) in the non-interventional International Operations Hypoglycemia Assessment Tool (IO HAT) study.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c6b2b61cb37046cd9331a7704bec6bf
https://pubmed.ncbi.nlm.nih.gov/33442106
https://pubmed.ncbi.nlm.nih.gov/33442106
Publikováno v:
Nature reviews. Drug discovery. 16(9)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2864f557bb66dfe930f520b8afcfe898
https://pubmed.ncbi.nlm.nih.gov/28799542
https://pubmed.ncbi.nlm.nih.gov/28799542
Autor:
Angela Murphy, Su-Yen Goh, Carlos Augusto Yepes Cortés, Roberto Mirasol, M Hesham El-Hefnawy, Ana María Gómez, Faruque Pathan, Anand B. Jain, Zhulin Ma, Achmad Rudijanto, Salah Abusnana, Rifat Emral
Publikováno v:
Diabetes research and clinical practice. 134
Aims Hypoglycemia constitutes a significant barrier to achieving glycemic control with insulin in both type 1 and type 2 diabetes. Historically, it has been difficult to accurately verify the rates of hypoglycemia within a clinical setting and there
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef65a32f4fd35896c37496f7d4b1d547
https://pubmed.ncbi.nlm.nih.gov/28951336
https://pubmed.ncbi.nlm.nih.gov/28951336
Publikováno v:
Diabetes Research and Clinical Practice. 100:S10-S16
Aim To determine the safety and effectiveness of insulin detemir (IDet) in type 2 diabetes patients from the ASEAN cohort of the A 1 chieve study. Methods Patients from Indonesia, Malaysia, Philippines and Singapore prescribed IDet at the discretion
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::72c21f4e209e82deadcc92f4be2f29af
https://doi.org/10.1016/s0168-8227(13)70004-4
https://doi.org/10.1016/s0168-8227(13)70004-4
Publikováno v:
Diabetes Research and Clinical Practice. 100:S24-S29
Aim To evaluate the safety and effectiveness of biphasic insulin aspart 30 (BIAsp 30) in ASEAN type 2 diabetes (T2D) patients switched from biphasic human insulin (BHI) in the non-interventional 24-week A 1 chieve study. Methods Indonesian, Malaysian
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c492850c9be6bafe95129e9fff4931bd
https://doi.org/10.1016/s0168-8227(13)70006-8
https://doi.org/10.1016/s0168-8227(13)70006-8
Publikováno v:
Diabetes Research and Clinical Practice. 100:S3-S9
Aim To determine the safety and effectiveness of biphasic insulin aspart 30 (BIAsp 30) in the ASEAN cohort of the A 1 chieve study. Methods Type 2 diabetes patients from Indonesia, Malaysia, Philippines and Singapore prescribed BIAsp 30 therapy were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::370d716f6d37daf8078d9badc66ecac1
https://doi.org/10.1016/s0168-8227(13)70003-2
https://doi.org/10.1016/s0168-8227(13)70003-2
Publikováno v:
Diabetes Research and Clinical Practice. 100:S35-S40
Aim To evaluate the safety and effectiveness of biphasic insulin aspart 30 (BIAsp 30) in Filipino patients with type 2 diabetes previously treated with biphasic human insulin 30 (BHI 30). Methods: Safety and effectiveness outcomes were measured in al
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5a2a8de19e0990ece24e5297e6c90d9e
https://doi.org/10.1016/s0168-8227(13)70008-1
https://doi.org/10.1016/s0168-8227(13)70008-1
Autor:
Shweta Uppal, Wan Mohamad Wan Bebakar, Siew Pheng Chan, Zanariah Hussein, Nor Azmi Kamaruddin, Anand B. Jain
Publikováno v:
Diabetes research and clinical practice. 133
Aims The present Malaysian cohort analysis determined the prevalence of hypoglycemia among patients with type 1 diabetes mellitus (T1DM) or type 2 diabetes mellitus (T2DM) attending primary care- or hospital-based diabetes clinics in Malaysia and the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8686174b3ebd77101c3e0299d42fee20
https://pubmed.ncbi.nlm.nih.gov/28888148
https://pubmed.ncbi.nlm.nih.gov/28888148